GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oncoclinicas Do Brasil Servicos Medicos SA (BSP:ONCO3) » Definitions » Research & Development

Oncoclinicas Do Brasil Servicos Medicos (BSP:ONCO3) Research & Development : R$0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Oncoclinicas Do Brasil Servicos Medicos Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Oncoclinicas Do Brasil Servicos Medicos's Research & Development for the three months ended in Sep. 2024 was R$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was R$0 Mil.

Oncoclinicas Do Brasil Servicos Medicos Research & Development Historical Data

The historical data trend for Oncoclinicas Do Brasil Servicos Medicos's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncoclinicas Do Brasil Servicos Medicos Research & Development Chart

Oncoclinicas Do Brasil Servicos Medicos Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial - - - - -

Oncoclinicas Do Brasil Servicos Medicos Quarterly Data
Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Oncoclinicas Do Brasil Servicos Medicos Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncoclinicas Do Brasil Servicos Medicos  (BSP:ONCO3) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Oncoclinicas Do Brasil Servicos Medicos Research & Development Related Terms

Thank you for viewing the detailed overview of Oncoclinicas Do Brasil Servicos Medicos's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncoclinicas Do Brasil Servicos Medicos Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Oncoclinicas Do Brasil Servicos Medicos SA (BSP:ONCO3) » Definitions » Research & Development
Comparable Companies
BSP:MATD3 BSP:KRSA3 HCA SAU:4013 SZSE:300015 HKSE:06618 XTER:FRE BKK:BDMS XKLS:5225 BSP:RDOR3 XTER:FME UHS CHE NSE:APOLLOHOSP ASX:RHC DVA AGL ACHC BOM:543220 EHC
Traded in Other Exchanges
N/A
Address
Avenida Presidente Juscelino Kubitschek, No. 510, 2nd Floor, Vila Nova Conceicao, Sao Paulo, SP, BRA, 04543-906
Website
https://ri.grupooncoclinicas.com
Oncoclinicas Do Brasil Servicos Medicos SA is engaged in the management and administration of oncological services. It has specialists in the areas of oncology, radiotherapy, hematology and bone marrow transplantation, complementary care.

Oncoclinicas Do Brasil Servicos Medicos Headlines

No Headlines